Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Chemmedchem
|
January 26, 2024
Design, Synthesis, and Evaluation of An Anti-trypanosomal [1,2,4]Triazolo[1,5-a]pyrimidine Probe for Photoaffinity Labeling Studies
Bobby Lucero, Karol R Francisco, Carmine Varricchio, et al.
Journal of Neurochemistry
|
July 17, 2004
Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury
Valeria Conte, Kunihiro Uryu, Scott Fujimoto, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 17, 2016
Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related Tauopathies
Jane Kovalevich, Anne-Sophie Cornec, Yuemang Yao, et al.
Journal of Medicinal Chemistry
|
April 16, 2010
Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation
Carlo Ballatore, Kurt R Brunden, Francesco Piscitelli, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
MT-Stabilizer, Dictyostatin, Exhibits Prolonged Brain Retention and Activity: Potential Therapeutic Implications
Kurt R Brunden, Nicola M Gardner, Michael J James, et al.
Bioorganic & Medicinal Chemistry
|
June 22, 2012
Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure-activity relationship leads to selection of candidates with desirable in vivo properties
Carlo Ballatore, Alex Crowe, Francesco Piscitelli, et al.
Acta Neuropathologica Communications
|
October 1, 2016
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
Vishruti Makani, Bin Zhang, Heeoon Han, et al.
Pharmacological Research
|
December 18, 2010
The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies
Kurt R Brunden, Yuemang Yao, Justin S Potuzak, et al.
Molecular Neurodegeneration
|
November 9, 2018
A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
Bin Zhang, Yuemang Yao, Anne-Sophie Cornec, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2018
Design, synthesis and evaluation of photoactivatable derivatives of microtubule (MT)-active [1,2,4]triazolo[1,5-a]pyrimidines
Killian Oukoloff, Jane Kovalevich, Anne-Sophie Cornec, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Chemmedchem
|
January 26, 2024
Design, Synthesis, and Evaluation of An Anti-trypanosomal [1,2,4]Triazolo[1,5-a]pyrimidine Probe for Photoaffinity Labeling Studies
Bobby Lucero, Karol R Francisco, Carmine Varricchio, et al.
Journal of Neurochemistry
|
July 17, 2004
Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury
Valeria Conte, Kunihiro Uryu, Scott Fujimoto, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 17, 2016
Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related Tauopathies
Jane Kovalevich, Anne-Sophie Cornec, Yuemang Yao, et al.
Journal of Medicinal Chemistry
|
April 16, 2010
Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation
Carlo Ballatore, Kurt R Brunden, Francesco Piscitelli, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
MT-Stabilizer, Dictyostatin, Exhibits Prolonged Brain Retention and Activity: Potential Therapeutic Implications
Kurt R Brunden, Nicola M Gardner, Michael J James, et al.
Bioorganic & Medicinal Chemistry
|
June 22, 2012
Aminothienopyridazine inhibitors of tau aggregation: evaluation of structure-activity relationship leads to selection of candidates with desirable in vivo properties
Carlo Ballatore, Alex Crowe, Francesco Piscitelli, et al.
Acta Neuropathologica Communications
|
October 1, 2016
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
Vishruti Makani, Bin Zhang, Heeoon Han, et al.
Pharmacological Research
|
December 18, 2010
The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies
Kurt R Brunden, Yuemang Yao, Justin S Potuzak, et al.
Molecular Neurodegeneration
|
November 9, 2018
A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
Bin Zhang, Yuemang Yao, Anne-Sophie Cornec, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 17, 2018
Design, synthesis and evaluation of photoactivatable derivatives of microtubule (MT)-active [1,2,4]triazolo[1,5-a]pyrimidines
Killian Oukoloff, Jane Kovalevich, Anne-Sophie Cornec, et al.
Page
of 4